Evaluation of the Patient With Erectile Dysfunction

  • Jeffrey C. La Rochelle
  • Laurence A. Levine
Part of the Current Clinical Urology book series (CCU)


Evaluation of the male with erectile dysfunction (ED) has evolved over the past two decades. Although a complex array of diagnostic studies are available and may be employed in the appropriate subject, for the great majority of men these invasive, expensive, and on occasion painful studies are not necessary. Clearly, most men have a physiological etiology to their dysfunction and in fact, most of these men have a vascular cause. It seems that the fundamentals of medicine provide the most useful information, including a thorough medical history and physical exam as well as blood testing of serum glucose, lipids, and, when a hypogonadal etiology is suspected, semen testosterone.

There are several circumstances in which a more detailed analysis is in order, including patients who fail first-line therapy with oral pharmacotherapy and those with primary or traumatic ED. This chapter provides an up-to-date review of the diagnostic approach to the man with ED.

Key Words

Erectile dysfunction male sexual health 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Levine LA. Erectile dysfunction: causes, diagnosis, and treatment. Compr Thera 1989; 15: 54–58.Google Scholar
  2. 2.
    Kadioglu A, Kandirali E, Kendirci M, Sanli O, Ozsoy C. Incidentally diagnosed Peyronie’s disease in men presenting with erectile dysfunction. Int J Impot Res 2004; 16: 540–543.PubMedCrossRefGoogle Scholar
  3. 3.
    Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822–830.PubMedCrossRefGoogle Scholar
  4. 4.
    Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61.PubMedGoogle Scholar
  5. 5.
    Shiri R, Koskimäki J, Häkkinen J, et al. Effects of age, comorbity and lifestyle factors on erectile function: Tampere Ageing Male Urological Study (TAMUS). Eur Urol 2004; 45: 628–633.PubMedCrossRefGoogle Scholar
  6. 6.
    Gades NM, Nehra A, Jacobsen DJ, et al. Association between smoking and erectile function: a population-based study. Am J Epidem 2005; 161: 346–351.CrossRefGoogle Scholar
  7. 7.
    Saltzman EA, Guay AT, Jacobson J. Improvement in erectile function in men with organic erectile dysfunction by correction of elevated cholesterol levels: a clinical observation. J Urol 2004; 172: 255–258.PubMedCrossRefGoogle Scholar
  8. 8.
    Esposito K, Giugliano F, Di Palo C, et al. Effect of lifestyle changes in erectile dysfunction in obese men: a randomized controlled trial. JAMA 2004; 291: 2978–2984.PubMedCrossRefGoogle Scholar
  9. 9.
    Pourmand G, Alidaee MR, Rasuli S, Maleki A, Mehrsai A. Do cigarette smokers with erectile dysfunction benefit from stopping?: a prospective study. BJU Int 2004; 94: 1310–1313.PubMedCrossRefGoogle Scholar
  10. 10.
    Kolodny RC, Kahn CE, Goldstein HH. Sexual dysfunction in diabetic men. Diabetes 1974; 23: 306–309.PubMedGoogle Scholar
  11. 11.
    Corona G, Mannucci E, Mansani R, et al. Organic, relational and psychological factors in erectile dysfunction in men with diabetes mellitus. Eur Urol 2004; 46: 222–228.PubMedCrossRefGoogle Scholar
  12. 12.
    Rhoden EL, Ribeiro EP, Reidner CE, Teloken C, Souto CAV. Glycosylated haemoglobin levels and the severity of erectile function in diabetic men. BJU Int 2005; 95: 615–617.PubMedCrossRefGoogle Scholar
  13. 13.
    Romeo JH, Seftel AD, Madhun ZT, Aron DC. Sexual function in men with diabetes type 2: association with glycemic control. J Urol 2000; 163: 788–791.PubMedCrossRefGoogle Scholar
  14. 14.
    Raffaele R, Vecchio I, Giammuso B, Morgia G, Brunetto MB, Rampello L. Efficacy and safety of fixed-dose oral sildenafil in the treatment of sexual dysfunction in depressed patients with idiopathic Parkinson’s disease. Eur Urol 2002; 41: 382–386.PubMedCrossRefGoogle Scholar
  15. 15.
    Ghezzi A, Malvestiti GM, Baldini S, Zaffaroni M, Zibetti A. Erectile impotence in multiple sclerosis: a neurophysiological study. J Neurol 1995; 242: 123–126.PubMedCrossRefGoogle Scholar
  16. 16.
    Betts CD, Jones SJ, Fowler CG, Fowler CJ. Erectile dysfunction in multiple sclerosis-associated neurological and neurophsiological deficits, and treatment of the condition. Brain 1994; 117: 1303–1310.PubMedCrossRefGoogle Scholar
  17. 17.
    Aisen ML, Sanders AS. AUA Update Series: Sexual dysfunction in neurologic disease: mechanisms of disease and counseling approaches. American Urological Association, 1998.Google Scholar
  18. 18.
    Isojäarvi JIT, Repo M, Pakarinen AJ, Lukkarinen O, Myllylä VV. Carbamazepine, phenytoin, sex hormones, and sexual function in men with epilepsy. Epilepsia 1995; 36: 366–370.CrossRefGoogle Scholar
  19. 19.
    Murialdo G, Galimberti CA, Fonzi S, et al. Sex hormones and pituitary function in male epileptic patients with altered or normal sexuality. Epilepsia 1995; 36: 360–365.PubMedCrossRefGoogle Scholar
  20. 20.
    Nehra A, Moreland RB. Neurologic erectile dysfunction. Urol Clin No Amer 2001; 28: 289–308.Google Scholar
  21. 21.
    Harwood PJ, Grotz M, Eardley I, Giannoudis PV. Erectile dysfunction after fracture of the pelvis. J Bone Joint Surg (Br) 2005; 87B: 281–290.Google Scholar
  22. 22.
    Shenfeld OZ, Kiselgorf D, Gofrit ON, Verstandig AG, Landau EH, Pode D. The incidence and causes of erectile dysfunction after pelvic fractures associated with posterior urethral disruption. J Urol 2003; 169: 2173–2176.PubMedCrossRefGoogle Scholar
  23. 23.
    Moriel EZ, Mehringer CM, Schwartz M, Rajfer J. Cavernous artery obstruction following blunt trauma to the penis. J Urol 1993; 149: 599–601.PubMedGoogle Scholar
  24. 24.
    Nane I, Tefekli A, Armagan A, Sanli O, Kadioglu A. Penile vascular abnormalities observed longterm after surgical repair of penile fractures. Int J Urol 2004; 11: 316–320.PubMedCrossRefGoogle Scholar
  25. 25.
    Taylor JA, Kao TC, Albertsen PC, Shabsigh R. Bicycle riding and its relationship to the development of erectile dysfunction. J Urol 2004; 172: 1028–1031.PubMedCrossRefGoogle Scholar
  26. 26.
    Dettori JR, Koepsell TD, Cummings P, Corman JM. Erectile dysfunction after a long-distance cycling event: associations with bicycle characteristics. J Urol 2004; 172: 637–641.PubMedCrossRefGoogle Scholar
  27. 27.
    Lasaponara F, Paradiso M, Milan MGL, et al. Erectile dysfunction after kidney transplantation: our 22 years of experience. Transpl Proceed 2004; 36: 502–504.CrossRefGoogle Scholar
  28. 28.
    Abdel-Hamid I. Mechanisms of vasculogenic erectile dysfunction after kidney transplantation. BJU Int 2004; 94: 497–500.PubMedCrossRefGoogle Scholar
  29. 29.
    Morgentaler A, Bruning CO. AUA Update Series: Iatrogenic male sexual dysfunction. American Urological Association, 1996.Google Scholar
  30. 30.
    Thomas DR. Medications and sexual function. Clin Geriatr Med 2003; 19: 553–562.PubMedCrossRefGoogle Scholar
  31. 31.
    Elliott SP, Gulati M, Pasta DJ, Spitalny GM, Kane CJ, Yee R, Lue TF. Obstructive lower urinary tract symptoms correlate with erectile dysfunction. Urology 2004; 63: 1148–1152.PubMedCrossRefGoogle Scholar
  32. 32.
    Schiff JD, Mulhall JP. The link between LUTS and ED: clinical and basic science evidence. J Androl 2004; 25: 470–478.PubMedGoogle Scholar
  33. 33.
    Baldo O, Eardley I. Diagnosis and investigation of men with erectile dysfunction. J Men’s Health Gend 2005; 2: 79–86.CrossRefGoogle Scholar
  34. 34.
    Chaterjee R, Palla K, Kottaridis PD. Cavernosal arterial insufficiency and metabolic syndrome probably represent a common pathology of endothelial dysfunction in recipients of high-dose therapy and stem-cell transplantation (letter). JCO 2004; 22: 2253–2254.CrossRefGoogle Scholar
  35. 35.
    Deutsch S, Sherman L. Previously unrecognized diabetes mellitus in sexually impotent men. JAMA 1980; 244: 2430–2432.PubMedCrossRefGoogle Scholar
  36. 36.
    Sairam K, Kulinskaya E, Boustead GB, Hanbury DC, McNicholas TA. Prevalence of undiagnosed diabetes mellitus in male erectile dysfunction. BJU Int 2001; 88: 68–71.PubMedCrossRefGoogle Scholar
  37. 37.
    Bookstein JJ, Lang EV. Penile magnification pharmacoarteriography: details of intrapenile arterial anatomy. AJR 1987; 148: 883–888.PubMedGoogle Scholar
  38. 38.
    Mueller SC, Lue TF. Evaluation of vasculogenic impotence. Urol Clin No Amer 1988; 15: 65–76.Google Scholar
  39. 39.
    Diederichs W, Stief CG, Lue TF, Tanagho EA. Sympathetic inhibition of papaverine induced erection. J Urol 1991; 146: 195–198.PubMedGoogle Scholar
  40. 40.
    Donatucci CF, Lue TF. The combined intracavernous injection and stimulation test: diagnostic accuracy. J Urol 1992; 148: 61–62.PubMedGoogle Scholar
  41. 41.
    Pescatori ES, Hatzichristou DG, Namburi S, Goldstein I. A positive intracavernous injection test implies normal veno-occlusive but not necessarily normal aterial function: a hemodynamic study. J Urol 1994; 151: 1209–1216.PubMedGoogle Scholar
  42. 42.
    McMahon CG. Correlation of penile duplex ultrasonography, PBI, DICC, and angiography in the diagnosis of impotence. Int J Impot Res 1998; 10: 153–158.PubMedCrossRefGoogle Scholar
  43. 43.
    Benson CB, Aruny JE, Vickers MA. Correlation of duplex sonography with arteriography in patients with erectile dysfunction. AJR 1993; 160: 71–73.PubMedGoogle Scholar
  44. 44.
    Schwartz AN, Lowe MA, Ireton R, Berger RE, Richardson MI, Graney DO. A comparison of penile brachial index and angiography: evaluation of corpora cavernosa arterial inflow. J Urol 1990; 143: 510–513.PubMedGoogle Scholar
  45. 45.
    Chiou RK, Pomeroy BD, Chen WS, Anderson JC, Wobig RK, Taylor RJ. Hemodynamic patterns of pharmacologically induced erection: evaluation by color doppler sonography. J Urol 1998; 159: 109–112.PubMedCrossRefGoogle Scholar
  46. 46.
    Schwartz AN, Wang KY, Mack LA, et al. Evaluation of normal erectile function with color flow Doppler sonography. AJR 1989; 153: 1155–1160.PubMedGoogle Scholar
  47. 47.
    Bassiouny HS, Levine LA. Penile duplex sonography in the diagnosis of venogenic impotence. J Vasc Surg 1991; 13: 75–83.PubMedCrossRefGoogle Scholar
  48. 48.
    Lue TF, Mueller SC, Jow YR, I-Shweng Hwang T. Functional evaluation of penile arteries with duplex ultrasound in vasodilator-induced erection. Urol Clin No Amer 1989; 16: 799–807.Google Scholar
  49. 49.
    Quam JP, King BF, James EM, et al. Duplex and color Doppler sonographic evaluation of vasculogenic impotence. AJR 1989; 153: 1141–1147.PubMedGoogle Scholar
  50. 50.
    Benson CB, Vickers MA. Sexual impotence caused by vascular disease: diagnosis with duplex ultrasonography. AJR 1989; 153: 1149–1153.PubMedGoogle Scholar
  51. 51.
    Montague DK, Lakin M. False diagnoses of venous leak impotence. J Urol 1992; 148: 148–149.PubMedGoogle Scholar
  52. 52.
    Rao DS, Donatucci CF. Vasculogenic impotence-arterial and venous surgery. Urol Clin No Amer 2001; 28: 309–319.CrossRefGoogle Scholar
  53. 53.
    Lue TF, Hricak H, Schmidt RA, Tanagho EA. Functional evaluation of penile veins by cavernosography in papaverine-induced erection. J Urol 1986; 135: 479–482.PubMedGoogle Scholar
  54. 54.
    Shabsigh R, Fishman IJ, Toombs BD, Skolkin M. Venous leaks: anatomical and physiological observations. J Urol 1991; 146: 1260–1265.PubMedGoogle Scholar
  55. 55.
    Lowe MA, Schwartz AN, Berger RE. Controlled trial of infusion cavernosometry in impotent and potent men. J Urol 1991; 146: 783–785.PubMedGoogle Scholar
  56. 56.
    Vickers MA, Benson C, Dluhy R, Ball RA. The current cavernosometric criteria for corporovenous dysfunction are too strict. J Urol 1992; 147: 614–617.PubMedGoogle Scholar
  57. 57.
    Wespes E, Delcour C, Struyven J, Schulman CC. Pharmacocarnometry-cavernography in impotence. Br J Urol 1986; 58: 420–433.Google Scholar
  58. 58.
    Martins FE, Padma-Nathan H. Diffuse veno-occlusive dysfunction: the underlying hemodynamic abnormality resulting in failure to respond to intracavernous pharmacotherapy. J Urol 1996; 156: 1942–1946.PubMedCrossRefGoogle Scholar
  59. 59.
    Fuchs AM, Mehringer CM, Rajfer J. Anatomy of penile venous drainage in potent and impotent men during cavernosography. J Urol 1989; 141: 1353–1356.PubMedGoogle Scholar
  60. 60.
    Yu GW, Schwab FJ, Melograna FS, DePalma RG, Miller HC, Rickholt AL. Preoperative and postoperative dynamic cavernosography and cavernosometry: objective assessment of venous ligation for impotence. J Urol 1992; 147: 618–622.PubMedGoogle Scholar
  61. 61.
    Rajfer J, Mehringer M. Cavernosography following clinical failure of penile vein ligation for erectile dysfunction. J Urol 1990; 143: 514–517.PubMedGoogle Scholar
  62. 62.
    Mueller SC, Wallenberg-Pachaly HV, Voges GE, Schild HH. Comparison of selective internal iliac pharmaco-angiography, penile brachial index and duplex sonography with pulsed Doppler analysis for the evaluation of vasculogenic (arteriogenic) impotence. J Urol 1990; 143: 928–932.PubMedGoogle Scholar
  63. 63.
    Lurie AL, Bookstein JJ, Kessler WO. Posttraumatic impotence: angiographic evaluation. Radiology 1987; 165: 115–119.Google Scholar
  64. 64.
    Schwartz AN, Freidednberg D, Harley JD. Nonselective angiography after intracorporal papverine injection: an alternative technique for evaluating penile arterial integrity. Radiology 1988; 167: 249–253.PubMedGoogle Scholar
  65. 65.
    Padma-Nathan H. Neurologic evaluation of erectile dysfunction. Urol Clin No Amer 1988; 15: 77–86.Google Scholar
  66. 66.
    Levine LA, Carroll RA. Nocturnal penile tumescence and rigidity in men without complaints of erectile dysfunction using a new quantitative analysis software. J Urol 1994; 152: 1103–1107.PubMedGoogle Scholar
  67. 67.
    Benet AE, Rehman J, Holcomb RG, Melman A. The correlation between the new Rigiscan Plus software and the final diagnosis in the evaluation of erectile dysfunction. J Urol 1996; 156: 1947–1950.PubMedCrossRefGoogle Scholar
  68. 68.
    Bemelmans BLH, Meuleman EJH, Anten BWM, Doesburg WH, Van Kerrebroeck PEV, DeBruyne FMJ. Penile sensory disorders in erectile dysfunction: results of a compehnesive neuro-urophysiological diagnostic evaluation in 123 patients. J Urol 1991; 146: 777–782.PubMedGoogle Scholar
  69. 69.
    Stief CG, Kellner B, Gorek M, Jonas U. Smooth muscle electromyography. Urol Clin No Amer 2001; 28: 259–268.CrossRefGoogle Scholar
  70. 70.
    Stief CG, Djamillian M, Anton P, De Riese W, Allhoff EP, Jonas U. Single potential analysis of cavernous electrical activity in impotent patients: a possible diagnostic method for autonomic cavernous dysfunction and cavernous snooth muscle degeneration. J Urol 1991; 146: 771–776.PubMedGoogle Scholar
  71. 71.
    Wagner G, Gerstenberg T, Levin RJ. Electrical activity of corpus cavernosum during flaccidity and erection of the human penis: a new diagnostic method? J Urol 1989; 142: 723–725.PubMedGoogle Scholar
  72. 72.
    Sadovsky R, Mulhall JP. The potential value of erectile dysfunction inquiry and management. Int J Clin Practice 2003; 57: 601–608.Google Scholar
  73. 73.
    Montorsi F, Briganti A, Salonia A, et al. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol 2003; 44: 360–365.PubMedCrossRefGoogle Scholar
  74. 74.
    Gazzaruso C, Giordanetti S, De Amici E, et al. Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation 2004; 110: 22–26.PubMedCrossRefGoogle Scholar
  75. 75.
    El-Sakka A, Morsy AM. Screening for ischemic heart disease in patients with erectile dysfunction: role of doppler ultrasonography. Urology 2004; 64: 346–350.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2006

Authors and Affiliations

  • Jeffrey C. La Rochelle
  • Laurence A. Levine

There are no affiliations available

Personalised recommendations